<DOC>
	<DOCNO>NCT02330640</DOCNO>
	<brief_summary>This study design demonstrate onset antiplatelet effect 90mg bid dose ticagrelor rapid great 75 mg qd dose clopidogrel patient undergo CABG surgery .</brief_summary>
	<brief_title>A Single-center , Prospective , Randomized Study Antiplatelet Effects Ticagrelor Versus Clopidogrel Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting</brief_title>
	<detailed_description>Patients undergo coronary artery surgery routinely receive aspirin therapy , standard treatment preserve bypass graft patency . Although dual antiplatelet therapy post CABG recommend guideline , present study indicate patient could benefit dual anti-platelet therapy . Using clopidogrel+aspirin could significantly reduce early saphenous vein graft occlusion . . Many surgeon empirically prescribe dual anti-platelet therapy spite indeterminacy clinical effect . ticagrelor novel , reversibly bind , oral , direct-acting P2Y12-receptor antagonist . The ONSET/OFFSET Study also show ticagrelor achieve much rapid great platelet inhibition high-loading-dose clopidogrel patient stable CAD . ticagrelor novel , reversibly bind , oral , direct-acting P2Y12-receptor antagonist . The ONSET/OFFSET Study also show ticagrelor achieve much rapid great platelet inhibition high-loading-dose clopidogrel patient stable CAD .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Female and/or male ≥ 18 ＜80 year age Isolated CABG first time either pump Combined valvular surgery . A second surgery . Emergency surgery ( selective operation change emergency surgery special medical condition ) . Serum creatinine &gt; 130μmol/L . Oral clopidogrel therapy stop less 5 day surgery . Oral anticoagulation therapy ( warfarin ) withheld . History gastrointestinal vaginal bleeding , Active pathological bleeding ( e.g . active gastroduodenal ulcer cerebral haemorrhage ) , history postoperative gastrointestinal bleeding . Uric acid nephropathy , history postoperative gastrointestinal bleeding . History cerebral haemorrhage . Any condition may influence platelet count function . Postoperative chest drainage &gt; 200 ml/hr two hour , reoperation bleed persistent cardiac tamponade . Treated IABP ECMO operation . Any condition may put patient risk ( e.g. , recurrent ventricular arrhythmia , perioperative myocardial infarction , cancer ) . Contraindication aspirin , clopidogrel ticagrelor reason study drug administer ( e.g. , hypersensitivity , moderate severe liver disease ) . Previous enrollment investigational drug device study within 30 day . Being plan pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>CABG</keyword>
	<keyword>antiplatelet therapy</keyword>
	<keyword>ticagrelor</keyword>
</DOC>